Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines

ClinicalTrials.gov ID: NCT00512135

Public ClinicalTrials.gov record NCT00512135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Open-label, Multicenter, Repeat-dose Trial to Investigate the Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines

Study identification

NCT ID
NCT00512135
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merz Pharmaceuticals GmbH
Industry
Enrollment
801 participants

Conditions and interventions

Interventions

  • IncobotulinumtoxinA (Xeomin) (20 units) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 17, 2007
Primary completion
Dec 27, 2009
Completion
Dec 27, 2009
Last update posted
Apr 1, 2021

2007 – 2009

United States locations

U.S. sites
13
U.S. states
12
U.S. cities
13
Facility City State ZIP Site status
Skin Care Centre Los Angeles California 90069
About Skin Dermatology Englewood Colorado 80113
Centre for Cosmetic Enhancement Aventura Florida 33180
Brandt Coral Gables Florida 33146
Advanced Dermatology Research Institute Lincolnshire Illinois 60069
Laser &Skin Surgery Center of Indiana Carmel Indiana 46032
Coleman Metairie Louisiana 70006
Skin Care Physisians of Chestnut Hill Chestnut Hill Massachusetts 02467
Schlessinger Omaha Nebraska 68144
Image Dermatology P.C. Montclair New Jersey 07042
Narins White Plains New York 10604
Flynn Consulting PLLC Raleigh North Carolina 27608
Tennessee Clinical Research Center Nashville Tennessee 37215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00512135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 1, 2021 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00512135 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →